Aspire Biopharma Holdings, Inc. Share Price
ASBPAspire Biopharma Holdings, Inc. Stock Performance
Open $0.09 | Prev. Close $0.08 | Circuit Range N/A |
Day Range $0.08 - $0.09 | Year Range $0.08 - $11.92 | Volume 2,78,793 |
Average Traded $0.08 |
Aspire Biopharma Holdings, Inc. Share Price Chart
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Aspire Biopharma Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Jan-26 | $0.10 | $0.09 | -6.93% |
09-Jan-26 | $0.10 | $0.10 | -2.88% |
08-Jan-26 | $0.12 | $0.10 | -18.11% |
07-Jan-26 | $0.16 | $0.13 | +20.95% |
06-Jan-26 | $0.11 | $0.10 | -13.93% |
05-Jan-26 | $0.14 | $0.12 | -17.57% |
02-Jan-26 | $0.13 | $0.15 | +12.98% |